Palatin Technologies Inc
PTN16.980USD
-1.620-8.71%
Close 11/26, 16:00（ET）Quotes delayed by 15 min
16.53MMarket Cap
LossP/E TTM
More Details of Palatin Technologies Inc Company
Palatin Technologies, Inc. is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin receptor system. The Company’s product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its new product development activities focus primarily on MC1r agonists, with the potential to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease. It is also developing peptides that are active at more than one melanocortin receptor, and MC4r peptide and small molecule agonists with potential utility in obesity and metabolic-related disorders, including rare disease and orphan indications. Its product candidates include PL9643 for dry eye disease and PL8177 for the treatment of ulcerative colitis.
Palatin Technologies Inc Info
Ticker SymbolPTN
Company namePalatin Technologies Inc
IPO dateDec 21, 1999
CEODr. Carl Spana, Ph.D.
Number of employees30
Security typeOrdinary Share
Fiscal year-endDec 21
Address4B Cedar Brook Drive
CityCRANBURY
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code08512
Phone16094952200
Websitehttps://www.palatin.com/
Ticker SymbolPTN
IPO dateDec 21, 1999
CEODr. Carl Spana, Ph.D.
Company Executives of Palatin Technologies Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Carl Spana, Ph.D.
Dr. Carl Spana, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
5.84K
-5.58%
Mr. Stephen T. Wills, CPA
Mr. Stephen T. Wills, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary
5.31K
-4.13%
Mr. Joseph Stanley Hull
Mr. Joseph Stanley Hull
Independent Director
Independent Director
845.00
+39.67%
Dr. Anthony M. Manning, Ph.D.
Dr. Anthony M. Manning, Ph.D.
Independent Director
Independent Director
722.00
+49.79%
Ms. Arlene M. Morris
Ms. Arlene M. Morris
Independent Director
Independent Director
--
--
Dr. John K. A. Prendergast
Dr. John K. A. Prendergast
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert K. Deveer, Jr.
Mr. Robert K. Deveer, Jr.
Independent Director
Independent Director
--
--
Dr. Alan William Dunton, M.D.
Dr. Alan William Dunton, M.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Carl Spana, Ph.D.
Dr. Carl Spana, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
5.84K
-5.58%
Mr. Stephen T. Wills, CPA
Mr. Stephen T. Wills, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary
5.31K
-4.13%
Mr. Joseph Stanley Hull
Mr. Joseph Stanley Hull
Independent Director
Independent Director
845.00
+39.67%
Dr. Anthony M. Manning, Ph.D.
Dr. Anthony M. Manning, Ph.D.
Independent Director
Independent Director
722.00
+49.79%
Ms. Arlene M. Morris
Ms. Arlene M. Morris
Independent Director
Independent Director
--
--
Dr. John K. A. Prendergast
Dr. John K. A. Prendergast
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 24
Updated: Mon, Nov 24
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Logos Global Management LP
7.84%
Point72 Asset Management, L.P.
6.44%
Spana (Carl)
0.33%
Wills (Stephen T)
0.30%
deVeer (Robert K Jr)
0.15%
Other
84.95%
Shareholders
Shareholders
Proportion
Logos Global Management LP
7.84%
Point72 Asset Management, L.P.
6.44%
Spana (Carl)
0.33%
Wills (Stephen T)
0.30%
deVeer (Robert K Jr)
0.15%
Other
84.95%
Shareholder Types
Shareholders
Proportion
Venture Capital
7.84%
Hedge Fund
6.44%
Individual Investor
1.03%
Other
84.70%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
66
7.49K
0.77%
-87.80K
2025Q2
82
5.26M
11.31%
+492.63K
2025Q1
85
5.07M
10.99%
+221.02K
2024Q4
86
4.37M
16.81%
+1.70M
2024Q3
83
2.28M
10.81%
-1.78M
2024Q2
109
3.64M
20.41%
+1.60M
2024Q1
111
1.78M
11.91%
-743.00K
2023Q4
114
2.29M
17.05%
-582.75K
2023Q3
116
2.63M
22.43%
+838.36K
2023Q2
118
2.93M
25.24%
+1.19M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Spana (Carl)
6.19K
0.64%
+957.00
+18.30%
Sep 19, 2025
Wills (Stephen T)
5.54K
0.57%
+831.00
+17.65%
Sep 19, 2025
deVeer (Robert K Jr)
2.76K
0.28%
+240.00
+9.52%
Jun 20, 2025
Prendergast (John K. A. Ph.D.)
1.27K
0.13%
--
--
Sep 19, 2025
Dunton (Alan W)
845.00
0.09%
-1.00
-0.12%
Sep 19, 2025
Hull (Joseph Stanley)
845.00
0.09%
+240.00
+39.67%
Jun 20, 2025
Morris (Arlene M.)
831.00
0.09%
-1.00
-0.12%
Sep 19, 2025
Manning (Anthony M)
722.00
0.07%
+240.00
+49.79%
Jun 20, 2025
View more
Related ETFs
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Aug 22, 2022
Merger
25→1
Aug 22, 2022
Merger
25→1
Aug 22, 2022
Merger
25→1
Aug 22, 2022
Merger
25→1
Date
Type
Ratio
Aug 22, 2022
Merger
25→1
Aug 22, 2022
Merger
25→1
Aug 22, 2022
Merger
25→1
Aug 22, 2022
Merger
25→1
FAQs
Who are the top five shareholders of Palatin Technologies Inc?
The top five shareholders of Palatin Technologies Inc are:
Spana (Carl) holds 6.19K shares, accounting for 0.64% of the total shares.
Wills (Stephen T) holds 5.54K shares, accounting for 0.57% of the total shares.
deVeer (Robert K Jr) holds 2.76K shares, accounting for 0.28% of the total shares.
Prendergast (John K. A. Ph.D.) holds 1.27K shares, accounting for 0.13% of the total shares.
Dunton (Alan W) holds 845.00 shares, accounting for 0.09% of the total shares.
Spana (Carl) holds 6.19K shares, accounting for 0.64% of the total shares.
Wills (Stephen T) holds 5.54K shares, accounting for 0.57% of the total shares.
deVeer (Robert K Jr) holds 2.76K shares, accounting for 0.28% of the total shares.
Prendergast (John K. A. Ph.D.) holds 1.27K shares, accounting for 0.13% of the total shares.
Dunton (Alan W) holds 845.00 shares, accounting for 0.09% of the total shares.
What are the top three shareholder types of Palatin Technologies Inc?
The top three shareholder types of Palatin Technologies Inc are:
Logos Global Management LP
Point72 Asset Management, L.P.
Spana (Carl)
Logos Global Management LP
Point72 Asset Management, L.P.
Spana (Carl)
How many institutions hold shares of Palatin Technologies Inc (PTN)?
As of 2025Q3, 66 institutions hold shares of Palatin Technologies Inc, with a combined market value of approximately 7.49K, accounting for 0.77% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -10.54%.
What is the biggest source of revenue for Palatin Technologies Inc?
In --, the -- business generated the highest revenue for Palatin Technologies Inc, amounting to -- and accounting for --% of total revenue.
